Auerbuch Victoria, Isberg Ralph R
Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111, USA.
Infect Immun. 2007 Jul;75(7):3561-70. doi: 10.1128/IAI.01497-06. Epub 2007 Apr 9.
Pathogenic Yersinia translocates effector proteins into target cells via a type III secretion system (TTSS), modulating the host immune response. A component of the TTSS translocon, LcrV, has been implicated in preventing inflammation through Toll-like receptor 2 (TLR2) by inducing expression of the anti-inflammatory cytokine interleukin-10 (IL-10). TLR2(-/-) mice were reported to be less susceptible to the enteropathogen Yersinia enterocolitica. To determine whether TLR2 also plays a role in recognition of the enteropathogen Yersinia pseudotuberculosis and whether this results in an immune response that is detrimental to the host, we evaluated the macrophage cytokine response to live Y. pseudotuberculosis and analyzed the susceptibility of TLR2(-/-) mice to enteropathogenic Yersinia. We find that Yersinia induction of macrophage IL-10 occurs independently of TLR2 and LcrV and is blocked by the TTSS. In particular, the TTSS effector protein YopJ, which inhibits production of the inflammatory cytokine tumor necrosis factor alpha (TNF-alpha), also inhibits IL-10 expression. Consistent with these results, IL-10 is undetectable in Y. pseudotuberculosis-infected mouse tissues until advanced stages of infection. In addition, we find that TLR2(-/-) mice (derived independently from those used in previous studies) do not display altered susceptibility to enteropathogenic Yersinia compared to wild-type mice. Tissue levels of IL-10, as well as the inflammatory cytokines TNF-alpha, IL-6, and gamma interferon and the chemokine macrophage chemotactic protein 1, are similar in TLR2(+/+) and TLR2(-/-) mice during enteropathogenic Yersinia infection. Therefore, the absence of TLR2 alone does not affect the cytokine response of macrophages to, or the in vivo growth and survival of, enteropathogenic Yersinia.
致病性耶尔森菌通过III型分泌系统(TTSS)将效应蛋白转运到靶细胞中,从而调节宿主免疫反应。TTSS转运孔蛋白的一个组分LcrV,通过诱导抗炎细胞因子白细胞介素-10(IL-10)的表达,参与通过Toll样受体2(TLR2)预防炎症。据报道,TLR2基因敲除小鼠对肠道病原体小肠结肠炎耶尔森菌的易感性较低。为了确定TLR2是否也在肠道病原体假结核耶尔森菌的识别中发挥作用,以及这是否会导致对宿主有害的免疫反应,我们评估了巨噬细胞对活的假结核耶尔森菌的细胞因子反应,并分析了TLR2基因敲除小鼠对肠道致病性耶尔森菌的易感性。我们发现,耶尔森菌诱导巨噬细胞产生IL-10独立于TLR2和LcrV,并且被TTSS阻断。特别是,抑制炎性细胞因子肿瘤坏死因子α(TNF-α)产生的TTSS效应蛋白YopJ,也抑制IL-10的表达。与这些结果一致,在假结核耶尔森菌感染的小鼠组织中,直到感染后期才检测到IL-10。此外,我们发现,与野生型小鼠相比,TLR2基因敲除小鼠(独立于先前研究中使用的小鼠获得)对肠道致病性耶尔森菌的易感性没有改变。在肠道致病性耶尔森菌感染期间,TLR2基因敲除小鼠和野生型小鼠体内IL-10以及炎性细胞因子TNF-α、IL-6和γ干扰素以及趋化因子巨噬细胞趋化蛋白1的组织水平相似。因此,单独缺失TLR2不会影响巨噬细胞对肠道致病性耶尔森菌的细胞因子反应,也不会影响其在体内的生长和存活。